Devon Jeltema

8PUBLICATIONS
25CO-AUTHORS
Pacific Peoples social determinants of healthMolecular targetsInnate immunityMolecular imaging (incl. electron microscopy and neutron diffraction)Instrumental methods (excl. immunological and bioassay methods)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 04, 2026
PARP7 protects the lung epithelial barrier from diverse environmental threats.

Devon Jeltema, Kun Yang, Joshua J Baty

|Jul 09, 2025
The IFN I response in tumor cells is shaped by PARP7-p300/CBP interactions through distinct loss- and gain-of-function mechanisms.

Ivan Rodriguez Siordia, Sonja Rieth, Rory Morgan

|May 06, 2025
Targeting Innate Immune Checkpoint TREX1 Is a Safe and Effective Immunotherapeutic Strategy in Cancer.

Cong Xing, Xintao Tu, Wanwan Huai

|Mar 07, 2025
Dynamic STING repression orchestrates immune cell development and function.

Kennady Knox, Devon Jeltema, Nicole Dobbs

|Feb 19, 2025
PARP7 inhibits type I interferon signaling to prevent autoimmunity and lung disease.

Devon Jeltema, Kennady Knox, Nicole Dobbs

|Jan 27, 2023
STING trafficking as a new dimension of immune signaling.

Devon Jeltema, Kennady Abbott, Nan Yan

Pageof 2

Frequent Collaborators

6 joint publications

Nan Yan

5 joint publications

Kennady Knox

5 joint publications

Kun Yang

5 joint publications

Cong Xing